Join the UCSF spinout ReValve Med team and help develop and test percutaneous solutions to failed heart valves. ReValve Med is developing […]
Lead Engineer Opening at ReValve Med
Category: Uncategorized
$4M Seed Round Focused on Glaucoma Treatment
Avisi Technologies, a 2020 Rosenman Innovator, raised $4.06 million to accelerate clinical development of its VisiPlate product, an ocular implant […]
Deep Blue Medical Advances gains FDA 510(k) for T-Line Hernia Mesh
2019 Rosenman Innovator, Deep Blue Medical Advances, received an additional 510(k) clearance from the FDA for its T-Line Hernia Mesh […]
Avenda Health Earns FDA Clearance
The FDA recently granted 510(k) clearance to Avenda Health, a Rosenman Innovator company, for its prostate cancer mapping platform. Using […]
Alio Raises $18M in Series C Round
Alio, a 2015 Rosenman Innovator, has raised $18 million in a Series C funding round. Specializing in wearable technology for […]
Efemoral Medical Closes Series A1
Efemoral Medical, a start-up developing a bioresorbable scaffold designed to treat peripheral arterial disease, closed $4.9M Series A1 fund. The […]
CardieX Acquires Blumio
Blumio, a Rosenman Innovator company, has recently been acquired by CardieX. Specializing in wearable sensor technologies for cardiovascular health disorders, […]
Allotrope Medical Receives STeP Designation from FDA
Allotrope Medical‘s surgical device, was recently granted FDA Safer Technologies Program (STeP) designation. This designation highlights the value of their […]
Hosting Interns: Pay it Forward, Get it Back
This summer, the Rosenman Institute recruited startups for a unique student program for the second year in a row: Foothill’s […]
More Than Skin Deep
Enspectra Health, a Rosenman Innovator and RISE company, recently announced its first patients’ enrollment in its virtual skin biopsy study. These non-invasive vivo images have the potential to become a groundbreaking tool for doctors and dermatologists.